異位妊娠藥物治療中動態(tài)監(jiān)測血清孕酮水平的價值

《異位妊娠藥物治療中動態(tài)監(jiān)測血清孕酮水平的價值》由會員上傳分享，免費在線閱讀，更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫。

1、異位妊娠藥物治療中動態(tài)監(jiān)測血清孕酮水平的價值作者：杜敏霞,任利華,黃,林單位：新鄉(xiāng)醫(yī)學院護理學院,河南新鄉(xiāng)貴陽醫(yī)學院第一附屬醫(yī)院婦產(chǎn)科，貴州貴陽【摘要】目的分析異位妊娠患者藥物治療前后動態(tài)監(jiān)測血清孕酮水平的價值。方法84例采取藥物治療的異位妊娠患者分為治療成功組和治療失敗組，治療前、治療后3d、7d檢測比較2組血清孕酮、血清絨毛膜促性腺激素β（βHCG）。結(jié)果治療前和治療后3d治療成功組血清孕酮水平明顯低于治療失敗組（P＜0.05），而2組間血清βHCG值的差異無統(tǒng)計學意義（P＞0.05）；治療后7d，治療

2、成功組血清孕酮值顯著低于治療失敗組（P＜0.01），2組間血清βHCG值的差異也有統(tǒng)計學意義（P＜0.05）。治療后3d和治療后7d治療成功組血清孕酮下降發(fā)生率均明顯高于治療失敗組（P＜0.05）。治療后3d2組間血清βHCG下降發(fā)生率無明顯差異（P＞0.05），而治療后7d治療成功組患者血清βHCG下降發(fā)生率明顯高于治療失敗組（P＜0.05）。結(jié)論異位妊娠藥物治療前監(jiān)測血清孕酮水平有助于更有效地篩選藥物治療病例；治療后血清孕酮下降是迅速判斷藥物治療效果的靈敏指標?！娟P(guān)鍵詞】異位妊娠；孕酮；絨毛膜促性腺激素

3、；藥物療法ValueofserumprogesteronelevelswithdynamicmonitoringduringdrugtreatmentofpatientswithectopicpregnancyDUMinxia1,RENLihua1,HUANGLin2(1.DepartmentofNursing,XinxiangMedicalCollege,Xinxiang453003,China；2.theFirstAffiliatedHospitalofGuiyangMedicalCollege,Guiyang550000,China

4、)Abstract:ObjectiveToanalyzethevalueofserumprogesteronelevelswithdynamicmonitoringpreandpostdrugtreatmentonpatientswithectopicpregnancy.MethodsEightyfourpatientswithectopicpregnancy,whoweretreatmentwithdrug,weredividedintotreatmentsuccessfulgroupandtreatmentfaliuregroup.

5、Serumprogesteroneandchorionicgonadotrophinβweredetectedandcomparedbetweentwogroupspretreatmentandinthethirddayandtheseventhdayposttreatment.ResultsThelevelofserumprogesteroneintreatmentsuccessfulgroupwaslowerthanthatintreatmentfaliuregrouppretreatmentandinthethirdd

6、ayposttreatment（P＜0.05）,buttherewasnosignificantdifferenceofchorionicgonadotrophinβbetweentwogroups（P＞0.05）.Thelevelofserumprogesteroneintreatmentsuccessfulgroupwasobviouslylowerthanthatintreatmentfaliuregroupintheseventhdayposttreatment（P＜0.01）,andtherewassignifica

7、ntdifferenceofchorionicgonadotrophinβbetweentwogroups(P＜0.05).Thedeclinerateofserumprogesteroneintreatmentsuccessfulgroupinthethirddayandintheseventhdayposttreatmentwassignificantlyhigherthanthatinthefailuretreatmentgroup（P＜0.05）,buttherewasnosignificantdifferenceofc

8、horionicgonadotrophinβbetweentwogroupinthethirddayposttreatment（P＞0.05）.The